Peter H. Goff

1.8k total citations
39 papers, 1.4k citations indexed

About

Peter H. Goff is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Peter H. Goff has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Peter H. Goff's work include Polyomavirus and related diseases (11 papers), Influenza Virus Research Studies (9 papers) and Full-Duplex Wireless Communications (8 papers). Peter H. Goff is often cited by papers focused on Polyomavirus and related diseases (11 papers), Influenza Virus Research Studies (9 papers) and Full-Duplex Wireless Communications (8 papers). Peter H. Goff collaborates with scholars based in United States, Austria and Tunisia. Peter H. Goff's co-authors include Peter Palese, Dirk Eggink, Frederick W. Alt, Shan Zha, Luis Martínez‐Gil, Rong Hai, Adolfo Garcı́a-Sastre, Yu Zhang, Harin Patel and Florian Krammer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Peter H. Goff

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter H. Goff United States 18 686 520 451 312 201 39 1.4k
David Feltquate United States 14 373 0.5× 576 1.1× 226 0.5× 348 1.1× 131 0.7× 28 1.2k
Nadia V. Giannakopoulos United States 12 521 0.8× 1.0k 1.9× 264 0.6× 350 1.1× 323 1.6× 15 1.6k
David R. McGivern United States 25 639 0.9× 341 0.7× 916 2.0× 156 0.5× 378 1.9× 44 2.0k
Bryan Boyd United States 10 589 0.9× 486 0.9× 758 1.7× 97 0.3× 273 1.4× 11 1.5k
Michiel van Gent Netherlands 13 504 0.7× 785 1.5× 349 0.8× 354 1.1× 375 1.9× 23 1.4k
Jens Zerrahn Germany 20 356 0.5× 1.2k 2.3× 634 1.4× 344 1.1× 189 0.9× 27 2.0k
Frank Liang Sweden 17 502 0.7× 850 1.6× 220 0.5× 150 0.5× 317 1.6× 26 1.4k
Fernando Esquivel‐Guadarrama Mexico 21 509 0.7× 1.1k 2.2× 357 0.8× 416 1.3× 310 1.5× 49 1.8k
Michael P. Rudolf Switzerland 17 628 0.9× 451 0.9× 427 0.9× 198 0.6× 70 0.3× 33 1.4k
Caroline Demeret France 22 564 0.8× 298 0.6× 576 1.3× 217 0.7× 143 0.7× 38 1.2k

Countries citing papers authored by Peter H. Goff

Since Specialization
Citations

This map shows the geographic impact of Peter H. Goff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Goff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Goff more than expected).

Fields of papers citing papers by Peter H. Goff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Goff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Goff. The network helps show where Peter H. Goff may publish in the future.

Co-authorship network of co-authors of Peter H. Goff

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Goff. A scholar is included among the top collaborators of Peter H. Goff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Goff. Peter H. Goff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pulliam, Thomas H., Peter H. Goff, Kimberly S. Smythe, et al.. (2024). Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses. Journal for ImmunoTherapy of Cancer. 12(10). e009803–e009803. 5 indexed citations
2.
Akaike, Tomoko, et al.. (2024). Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy. Journal for ImmunoTherapy of Cancer. 12(7). e009396–e009396. 3 indexed citations
3.
Goff, Peter H., et al.. (2023). Efficacy of Single-Fraction Postoperative Radiotherapy in Resected, Early-Stage Merkel Cell Carcinoma with High-Risk Features. International Journal of Radiation Oncology*Biology*Physics. 117(2). e298–e298. 1 indexed citations
4.
Anderson, A. C., Robert D. Stewart, Peter H. Goff, et al.. (2023). Intensity-Modulated Neutron Therapy (IMNT) for Head and Neck Cancer: Early Toxicity Outcomes. International Journal of Radiation Oncology*Biology*Physics. 117(2). e561–e562.
5.
6.
Cao, Ning, Danielle P. Johnson, Eric C. Ford, et al.. (2023). Preclinical Ultra-High Dose Rate (FLASH) Proton Radiation Therapy System for Small Animal Studies. Advances in Radiation Oncology. 9(3). 101425–101425. 12 indexed citations
7.
Goff, Peter H., Daniel S. Hippe, Kristina Lachance, et al.. (2023). Postoperative Radiation Therapy Is Indicated for “Low-Risk” Pathologic Stage I Merkel Cell Carcinoma of the Head and Neck Region but Not for Other Locations. Advances in Radiation Oncology. 9(2). 101364–101364. 4 indexed citations
8.
Schaub, Stephanie K., Peter H. Goff, Daniel S. Hippe, et al.. (2023). Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma. Journal of the American Academy of Dermatology. 90(2). 261–268. 5 indexed citations
9.
10.
Goff, Peter H., Jing Zeng, Ramesh Rengan, & Stephanie K. Schaub. (2021). Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer. Seminars in Radiation Oncology. 31(2). 133–139. 5 indexed citations
11.
Goff, Peter H., Kristina Lachance, Stephanie K. Schaub, et al.. (2020). Primary Tumor Location As a Potential Risk Factor for Local Recurrence in Resected, Low-risk Merkel Cell Carcinoma: Implications for Postoperative Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). S132–S132.
12.
Schaub, Stephanie K., Peter H. Goff, Alex Z. Fu, et al.. (2020). Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck. Advances in Radiation Oncology. 5(6). 1248–1254. 19 indexed citations
13.
Goff, Peter H., Tomoko Hayashi, Wenqian He, et al.. (2017). Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice. Journal of Virology. 91(19). 28 indexed citations
14.
15.
Goff, Peter H., Tomoko Hayashi, Luis Martínez‐Gil, et al.. (2015). Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses. Journal of Virology. 89(6). 3221–3235. 97 indexed citations
16.
Martínez‐Gil, Luis, et al.. (2013). A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis. Antiviral Research. 100(1). 29–37. 9 indexed citations
17.
Goff, Peter H., Dirk Eggink, Christopher W. Seibert, et al.. (2013). Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies. PLoS ONE. 8(11). e79194–e79194. 55 indexed citations
18.
Zha, Shan, Wenxia Jiang, Yuko Fujiwara, et al.. (2011). Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions. Proceedings of the National Academy of Sciences. 108(5). 2028–2033. 74 indexed citations
19.
Zha, Shan, Chunguang Guo, Cristian Boboilă, et al.. (2010). ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks. Nature. 469(7329). 250–254. 158 indexed citations
20.
Li, Gang�, Frederick W. Alt, Hwei-Ling Cheng, et al.. (2008). Lymphocyte-Specific Compensation for XLF/Cernunnos End-Joining Functions in V(D)J Recombination. Molecular Cell. 31(5). 631–640. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Feltquate Breakdown of academic impact, for papers by Nadia V. Giannakopoulos Breakdown of academic impact, for papers by David R. McGivern Breakdown of academic impact, for papers by Bryan Boyd Breakdown of academic impact, for papers by Michiel van Gent Breakdown of academic impact, for papers by Jens Zerrahn Breakdown of academic impact, for papers by Frank Liang Breakdown of academic impact, for papers by Fernando Esquivel‐Guadarrama Breakdown of academic impact, for papers by Michael P. Rudolf Breakdown of academic impact, for papers by Caroline Demeret
Rankless by CCL
2026